Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Opposing Contributions of GABAergic and Glutamatergic Ventral Pallidal Neurons to Motivational Behaviors.

Stephenson-Jones M, Bravo-Rivera C, Ahrens S, Furlan A, Xiao X, Fernandes-Henriques C, Li B.

Neuron. 2020 Jan 10. pii: S0896-6273(19)31048-7. doi: 10.1016/j.neuron.2019.12.006. [Epub ahead of print]

PMID:
31948733
2.

Identifying appropriate outcomes to help evaluate the impact of the Canadian Guideline for Safe and Effective Use of Opioids for Non-Cancer Pain.

Allen M, Sproule B, MacDougall P, Furlan A, Murphy L, Debono VB, Buckley N.

BMC Anesthesiol. 2020 Jan 7;20(1):6. doi: 10.1186/s12871-020-0930-4.

3.

Predictive factors for sleep apnoea in patients on opioids for chronic pain.

Chung F, Wong J, Bellingham G, Lebovic G, Singh M, Waseem R, Peng P, George CFP, Furlan A, Bhatia A, Clarke H, Juurlink DN, Mamdani MM, Horner R, Orser BA, Ryan CM; Op-Safe Investigators .

BMJ Open Respir Res. 2019 Dec 23;6(1):e000523. doi: 10.1136/bmjresp-2019-000523. eCollection 2019.

4.

Cross-sectional imaging of seminal vesicles and vasa deferentia.

Catania R, Dasyam N, Furlan A, Borhani AA.

Abdom Radiol (NY). 2020 Jan 2. doi: 10.1007/s00261-019-02368-7. [Epub ahead of print] Review.

PMID:
31897685
5.

Changes in Opioid Prescribing Behaviors among Family Physicians Who Participated in a Weekly Tele-Mentoring Program.

Díaz S, Zhao J, Cronin S, Jaglal S, Bombardier C, Furlan AD.

J Clin Med. 2019 Dec 19;9(1). pii: E14. doi: 10.3390/jcm9010014.

6.

Small-Molecule Modulators of Mitochondrial Channels as Chemotherapeutic Agents.

Parrasia S, Mattarei A, Furlan A, Zoratti M, Biasutto L.

Cell Physiol Biochem. 2019;53(S1):11-43. doi: 10.33594/000000192. Review.

7.

Liver stiffness measurement in patients with nodular regenerative hyperplasia undergoing magnetic resonance elastography.

Cannella R, Minervini MI, Rachakonda V, Bollino G, Furlan A.

Abdom Radiol (NY). 2019 Dec 13. doi: 10.1007/s00261-019-02367-8. [Epub ahead of print]

PMID:
31834457
8.

Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Borhani AA, Dewan R, Furlan A, Seiser N, Zureikat AH, Singhi AD, Boone B, Bahary N, Hogg ME, Lotze M, Iii HJZ, Tublin ME.

AJR Am J Roentgenol. 2019 Dec 4:1-8. doi: 10.2214/AJR.19.21152. [Epub ahead of print]

PMID:
31799875
9.

Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J.

AJR Am J Roentgenol. 2020 Jan;214(1):W20-W26. doi: 10.2214/AJR.19.21267. Epub 2019 Nov 12.

PMID:
31714842
10.

Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.

Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, Nikiforova MN, Wald AI, Kaya C, Nikiforov YE, Favazza L, He J, McGrath K, Fasanella KE, Brand RE, Lennon AM, Furlan A, Dasyam AK, Zureikat AH, Zeh HJ, Lee K, Bartlett DL, Slivka A.

Gastroenterology. 2019 Oct 31. pii: S0016-5085(19)41481-9. doi: 10.1053/j.gastro.2019.10.028. [Epub ahead of print]

11.

Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.

Fraum TJ, Cannella R, Ludwig DR, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Shetty AS, Borhani AA, Furlan A, Fowler KJ.

Eur Radiol. 2020 Feb;30(2):996-1007. doi: 10.1007/s00330-019-06448-6. Epub 2019 Oct 25.

PMID:
31654212
12.

Severe malnutrition after bariatric surgery and clinic manifestations of infection.

Furlan AAC, Junqueira-Franco MVM, Oliveira JCS, Favaris JWS, Marchini JS, Cunha SFC.

Rev Assoc Med Bras (1992). 2019 Oct 10;65(9):1151-1155. doi: 10.1590/1806-9282.65.9.1151. eCollection 2019.

13.

HEXIM1 Diffusion in the Nucleus Is Regulated by Its Interactions with Both 7SK and P-TEFb.

Furlan A, Gonzalez-Pisfil M, Leray A, Champelovier D, Henry M, Le Nézet C, Bensaude O, Lefranc M, Wohland T, Vandenbunder B, Bidaux G, Héliot L.

Biophys J. 2019 Nov 5;117(9):1615-1625. doi: 10.1016/j.bpj.2019.09.019. Epub 2019 Sep 20.

14.

Order-disorder transition in a two-dimensional associating lattice gas.

Furlan AP, Oliveira TJ, Stilck JF, Dickman R.

Phys Rev E. 2019 Aug;100(2-1):022109. doi: 10.1103/PhysRevE.100.022109.

PMID:
31574678
15.

Project ECHO: Building capacity to manage complex conditions in rural, remote and underserved areas.

Furlan AD, Pajer KA, Gardner W, MacLeod B.

Can J Rural Med. 2019 Oct-Dec;24(4):115-120. doi: 10.4103/CJRM.CJRM_20_18.

16.

A Retrospective Study of the Association between Pain Intensity and Opioid Use with Length of Stay during Musculoskeletal Inpatient Rehabilitation after Primary Knee and Hip Arthroplasty.

Sahota B, Alavinia SM, Kumbhare D, Sangha H, Flannery J, Furlan A.

PM R. 2019 Sep 9. doi: 10.1002/pmrj.12250. [Epub ahead of print]

PMID:
31498956
17.

Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.

Cannella R, Brancatelli G, Rangaswamy B, Minervini MI, Borhani AA, Furlan A.

Eur J Radiol. 2019 Oct;119:108633. doi: 10.1016/j.ejrad.2019.08.002. Epub 2019 Aug 6.

PMID:
31437747
18.

Concordance of angiography and cerebral biopsy results for suspected primary central nervous system vasculitis: A multi-center retrospective review.

Raghavan A, Wright JM, Huang Wright C, Shammassian BH, Onyewadume L, Momotaz H, Burant CJ, Sajatovic M, Carandang R, Furlan A, Calabrese L, DeGeorgia M.

Clin Neurol Neurosurg. 2019 Oct;185:105482. doi: 10.1016/j.clineuro.2019.105482. Epub 2019 Aug 9.

PMID:
31421586
19.

Utilization of Rehabilitation Services in Stroke: A Study Utilizing the Health and Retirement Study With Linked Medicare Claims Data.

Keptner KM, Smyth K, Koroukian S, Schluchter M, Furlan A.

Arch Phys Med Rehabil. 2019 Dec;100(12):2244-2250. doi: 10.1016/j.apmr.2019.06.017. Epub 2019 Aug 14.

PMID:
31421093
20.

Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocol.

Sandhu HK, Abraham C, Alleyne S, Balasubramanian S, Betteley L, Booth K, Carnes D, Furlan AD, Haywood K, Iglesias Urrutia CP, Lall R, Manca A, Mistry D, Nichols VP, Noyes J, Rahman A, Seers K, Shaw J, Tang NKY, Taylor S, Tysall C, Underwood M, Withers EJ, Eldabe S.

BMJ Open. 2019 Aug 8;9(8):e028937. doi: 10.1136/bmjopen-2019-028937.

21.

Efficacy of single-source rapid kV-switching dual-energy CT for characterization of non-uric acid renal stones: a prospective ex vivo study using anthropomorphic phantom.

Cannella R, Shahait M, Furlan A, Zhang F, Bigley JD, Averch TD, Borhani AA.

Abdom Radiol (NY). 2019 Aug 5. doi: 10.1007/s00261-019-02164-3. [Epub ahead of print]

PMID:
31385007
22.

Surgical Management of Ciliated Hepatic Foregut Cyst.

Ziogas IA, van der Windt DJ, Wilson GC, Furlan A, Nalesnik MA, Tohme S, Geller DA.

Hepatology. 2019 Jul 25. doi: 10.1002/hep.30877. [Epub ahead of print] No abstract available.

PMID:
31344277
23.

Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria.

Ludwig DR, Fraum TJ, Cannella R, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Fleckenstein J, Shetty AS, Borhani AA, Furlan A, Fowler KJ.

HPB (Oxford). 2019 Dec;21(12):1697-1706. doi: 10.1016/j.hpb.2019.04.007. Epub 2019 Jun 28.

PMID:
31262487
24.

Reply to "Letter to the editor".

Cannella R, Fowler KJ, Furlan A.

Abdom Radiol (NY). 2019 Sep;44(9):3209. doi: 10.1007/s00261-019-02092-2. No abstract available.

PMID:
31240327
25.

Mathematical models converge on PGC1α as the key metabolic integrator of SIRT1 and AMPK regulation of the circadian clock.

Furlan A, Jacquier M, Woller A, Héliot L, Duez H, Staels B, Lefranc M.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13171-13172. doi: 10.1073/pnas.1907751116. Epub 2019 Jun 25. No abstract available.

26.

Uncommon imaging evolutions of focal liver lesions in cirrhosis.

Vernuccio F, Cannella R, Porrello G, Calandra A, Midiri M, Furlan A, Brancatelli G.

Abdom Radiol (NY). 2019 Sep;44(9):3069-3077. doi: 10.1007/s00261-019-02101-4. Review.

PMID:
31222462
27.

User and system pitfalls in liver imaging with LI-RADS.

Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, Bashir MR, Furlan A, Sirlin CB.

J Magn Reson Imaging. 2019 Dec;50(6):1673-1686. doi: 10.1002/jmri.26839. Epub 2019 Jun 18. Review.

PMID:
31215119
28.

Models for predicting protein requirements for meat quail.

Nogueira MFZF, Marcato SM, Furlan AC, Zancanela V, Finco EM, de O Grieser D, Stanquevis CE, de Oliveira-Bruxel TM.

Anim Sci J. 2019 Jul;90(7):870-879. doi: 10.1111/asj.13172. Epub 2019 May 16.

PMID:
31099149
29.

Relationship between early prescription dispensing patterns and work disability in a cohort of low back pain workers' compensation claimants: a historical cohort study.

Carnide N, Hogg-Johnson S, Koehoorn M, Furlan AD, Côté P.

Occup Environ Med. 2019 Aug;76(8):573-581. doi: 10.1136/oemed-2018-105626. Epub 2019 May 15.

30.

LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.

Vernuccio F, Cannella R, Meyer M, Choudhoury KR, Gonzáles F, Schwartz FR, Gupta RT, Bashir MR, Furlan A, Marin D.

AJR Am J Roentgenol. 2019 Aug;213(2):W57-W65. doi: 10.2214/AJR.18.20979. Epub 2019 Apr 30.

PMID:
31039012
31.

Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.

Macleod LC, Yabes JG, Fam MM, Bandari J, Yu M, Maganty A, Furlan A, Filson CP, Davies BJ, Jacobs BL.

Eur Urol Focus. 2019 Apr 25. pii: S2405-4569(19)30124-5. doi: 10.1016/j.euf.2019.04.008. [Epub ahead of print]

PMID:
31031042
32.

Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.

Fam MM, Yabes JG, Macleod LC, Bandari J, Turner RM 2nd, Lopa SH, Furlan A, Filson CP, Davies BJ, Jacobs BL.

Urology. 2019 Aug;130:99-105. doi: 10.1016/j.urology.2019.02.037. Epub 2019 Mar 30.

PMID:
30940480
33.

Exploring the Dual Interaction of Natural Rhamnolipids with Plant and Fungal Biomimetic Plasma Membranes through Biophysical Studies.

Monnier N, Furlan AL, Buchoux S, Deleu M, Dauchez M, Rippa S, Sarazin C.

Int J Mol Sci. 2019 Feb 26;20(5). pii: E1009. doi: 10.3390/ijms20051009.

34.

Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.

Ludwig DR, Fraum TJ, Cannella R, Ballard DH, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Shetty AS, Borhani AA, Furlan A, Fowler KJ.

Abdom Radiol (NY). 2019 Jun;44(6):2116-2132. doi: 10.1007/s00261-019-01948-x.

PMID:
30798397
35.

Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

Cannella R, Borhani AA, Tublin M, Behari J, Furlan A.

Abdom Radiol (NY). 2019 May;44(5):1816-1824. doi: 10.1007/s00261-019-01931-6.

PMID:
30788556
36.

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB.

J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019. Review.

37.

Are psychogenic nonepileptic seizures risk factors for a worse outcome in patients with refractory mesial temporal epilepsy submitted to surgery? Results of a retrospective cohort study.

Furlan AER, da Silva SC Junior, Marques LHN, de Araujo Filho GM.

Epilepsy Behav. 2019 Apr;93:12-15. doi: 10.1016/j.yebeh.2019.01.036. Epub 2019 Feb 16.

PMID:
30780075
38.

Schwann Cell Precursors Generate the Majority of Chromaffin Cells in Zuckerkandl Organ and Some Sympathetic Neurons in Paraganglia.

Kastriti ME, Kameneva P, Kamenev D, Dyachuk V, Furlan A, Hampl M, Memic F, Marklund U, Lallemend F, Hadjab S, Calvo-Enrique L, Ernfors P, Fried K, Adameyko I.

Front Mol Neurosci. 2019 Jan 25;12:6. doi: 10.3389/fnmol.2019.00006. eCollection 2019.

39.

New Progress toward Validation of LI-RADS Version 2018.

Furlan A.

Radiology. 2019 Apr;291(1):81-82. doi: 10.1148/radiol.2019182890. Epub 2019 Jan 29. No abstract available.

PMID:
30694163
40.

Effect of aerobic exercise in the treatment of myofascial pain: a systematic review.

Ahmed S, Khattab S, Haddad C, Babineau J, Furlan A, Kumbhare D.

J Exerc Rehabil. 2018 Dec 27;14(6):902-910. doi: 10.12965/jer.1836406.205. eCollection 2018 Dec. Review.

41.

Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.

Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A.

AJR Am J Roentgenol. 2019 Mar;212(3):538-546. doi: 10.2214/AJR.18.20182. Epub 2018 Dec 17.

PMID:
30557050
42.

International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering.

Darnall BD, Juurlink D, Kerns RD, Mackey S, Van Dorsten B, Humphreys K, Gonzalez-Sotomayor JA, Furlan A, Gordon AJ, Gordon DB, Hoffman DE, Katz J, Kertesz SG, Satel S, Lawhern RA, Nicholson KM, Polomano RC, Williamson OD, McAnally H, Kao MC, Schug S, Twillman R, Lewis TA, Stieg RL, Lorig K, Mallick-Searle T, West RW, Gray S, Ariens SR, Sharpe Potter J, Cowan P, Kollas CD, Laird D, Ingle B, Julian Grove J, Wilson M, Lockman K, Hodson F, Palackdharry CS, Fillingim RB, Fudin J, Barnhouse J, Manhapra A, Henson SR, Singer B, Ljosenvoor M, Griffith M, Doctor JN, Hardin K, London C, Mankowski J, Anderson A, Ellsworth L, Davis Budzinski L, Brandt B, Hartley G, Nickels Heck D, Zobrosky MJ, Cheek C, Wilson M, Laux CE, Datz G, Dunaway J, Schonfeld E, Cady M, LeDantec-Boswell T, Craigie M, Sturgeon J, Flood P, Giummarra M, Whelan J, Thorn BE, Martin RL, Schatman ME, Gregory MD, Kirz J, Robinson P, Marx JG, Stewart JR, Keck PS, Hadland SE, Murphy JL, Lumley MA, Brown KS, Leong MS, Fillman M, Broatch JW, Perez A, Watford K, Kruska K, Sophia You D, Ogbeide S, Kukucka A, Lawson S, Ray JB, Wade Martin T, Lakehomer JB, Burke A, Cohen RI, Grinspoon P, Rubenstein MS, Sutherland S, Walters K, Lovejoy T.

Pain Med. 2019 Mar 1;20(3):429-433. doi: 10.1093/pm/pny228. No abstract available.

PMID:
30496540
43.

Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells.

Furlan A, Vercamer C, Heliot L, Wernert N, Desbiens X, Pourtier A.

Int J Oncol. 2019 Jan;54(1):29-40. doi: 10.3892/ijo.2018.4605. Epub 2018 Oct 24.

44.

The thickening of flexor tendons pulleys: a useful ultrasonographical sign in the diagnosis of psoriatic arthritis.

Furlan A, Stramare R.

J Ultrasound. 2018 Dec;21(4):309-314. doi: 10.1007/s40477-018-0325-2. Epub 2018 Oct 15.

45.

Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.

Cannella R, Borhani AA, Minervini MI, Tsung A, Furlan A.

Abdom Radiol (NY). 2019 Apr;44(4):1323-1330. doi: 10.1007/s00261-018-1788-5.

PMID:
30267107
46.

What interventions are effective to taper opioids in patients with chronic pain?

Sandhu H, Underwood M, Furlan AD, Noyes J, Eldabe S.

BMJ. 2018 Sep 27;362:k2990. doi: 10.1136/bmj.k2990. No abstract available.

PMID:
30262590
47.

[P-TEFb and Brd4: actors of the transcription pause release as therapeutical targets].

Furlan A, Agbazahou F, Henry M, Gonzalez-Pisfil M, Le Nézet C, Champelovier D, Fournier M, Vandenbunder B, Bidaux G, Héliot L.

Med Sci (Paris). 2018 Aug-Sep;34(8-9):685-692. doi: 10.1051/medsci/20183408015. Epub 2018 Sep 19. Review. French.

48.

[MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer].

Baldacci S, Kherrouche Z, Descarpentries C, Wislez M, Dansin E, Furlan A, Tulasne D, Cortot AB.

Rev Mal Respir. 2018 Oct;35(8):796-812. doi: 10.1016/j.rmr.2018.01.011. Epub 2018 Aug 31. Review. French.

PMID:
30174236
49.

CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors.

McGovern JM, Singhi AD, Borhani AA, Furlan A, McGrath KM, Zeh HJ 3rd, Bahary N, Dasyam AK.

AJR Am J Roentgenol. 2018 Nov;211(5):1020-1025. doi: 10.2214/AJR.17.19490. Epub 2018 Aug 30.

PMID:
30160983
50.

White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.

Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A, Bashir MR, Hecht EM, Kamaya A, Jambhekar K, Kamath A, Arora S, Bijan B, Ash R, Kassam Z, Chaudhry H, McGahan JP, Yacoub JH, McInnes M, Fung AW, Shanbhogue K, Lee J, Deshmukh S, Horvat N, Mitchell DG, Do RKG, Surabhi VR, Szklaruk J, Sirlin CB.

Abdom Radiol (NY). 2018 Oct;43(10):2625-2642. doi: 10.1007/s00261-018-1744-4.

PMID:
30155697

Supplemental Content

Loading ...
Support Center